BackExcelsior Biopharma Overview

Excelsior Biopharma Total Assets

Track Excelsior Biopharma's total assets ($1.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.42B
↑ 4.23% YoYΔ $57.70M vs prior year quarter

Peer trimmed avg / median

Loading

Excelsior Biopharma Total Assets History

Loading

Excelsior Biopharma vs. peers: Total Assets Comparison

Loading

Excelsior Biopharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Excelsior Biopharma (6496.TWO) FAQ

Excelsior Biopharma (6496.TWO) currently reports a total assets of $1.4B as of September 2026. That compares with $1.4B in the prior-year period — up 4.2% year over year. Use the charts on this page to explore Excelsior Biopharma's total assets history and peer comparisons.

Excelsior Biopharma's total assets increased from $1.4B to $1.4B — a 4.2% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Excelsior Biopharma reported $1.4B in total assets as of September 2026. That compares with $1.4B in the prior-year period — up 4.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $1.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Excelsior Biopharma, and consider following 6496.TWO for alerts when major investors trade the stock.